e-learning
resources
Munich 2014
Sunday, 07.09.2014
ILDs: connective tissue disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of lung lesions in
LAT
Y136F
mutant mice ∼Are they recognized as the models of IgG4 related lung disease?∼
Y. Waseda, S. Matsui, K. Yamada, S. Watanabe, R. Matsunuma, H. Takato, M. Kawano, M. Yasui, K. Kasahara (Kanazawa, Toyama, Komatsu, Japan)
Source:
International Congress 2014 – ILDs: connective tissue disease
Session:
ILDs: connective tissue disease
Session type:
Thematic Poster Session
Number:
721
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Waseda, S. Matsui, K. Yamada, S. Watanabe, R. Matsunuma, H. Takato, M. Kawano, M. Yasui, K. Kasahara (Kanazawa, Toyama, Komatsu, Japan). Evaluation of lung lesions in
LAT
Y136F
mutant mice ∼Are they recognized as the models of IgG4 related lung disease?∼. Eur Respir J 2014; 44: Suppl. 58, 721
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Relation of cytokine expression profile of T-cells from blood and bronchoalveolar lavage fluid with HRCT pattern in fibrosing interstitial lung diseases
Source: International Congress 2014 – ILDs 3
Year: 2014
Cytokine expression profiles of lymphocytes from bronchoalveolar lavage fluid and blood in patients with interstitial lung diseases(ILDs)
Source: International Congress 2014 – ILDs 5
Year: 2014
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Comparison of pulmonary versus extrapulmonary models of induced acute lung injury in rat
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013
Autophagy is not impaired in BALF alveolar macrophages in IPF: Preliminary results
Source: International Congress 2014 – ILDs 3
Year: 2014
Novel experimental model of maintained acute lung injury
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013
Expression phenotypes of CD4+ and CD8+ T lymphocytes in bronchoalveolar lavage fluid and blood in lung fibrosis
Source: International Congress 2014 – ILDs 2
Year: 2014
Collagen V overexpression correlates with IL-17+ cells in C57BL/6 mice pulmonary remodeling
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum
Source: International Congress 2014 – ILDs 2
Year: 2014
Multiple segmental lavage in the treatment of pulmonary alveolar proteinosis
Source: International Congress 2014 – ILDs 6
Year: 2014
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Protective effects of Dengzhanshengmai capsules on bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2014 – ILDs 3
Year: 2014
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Macrophage polarization in interstitial lung diseases
Source: International Congress 2014 – ILDs 2
Year: 2014
Ability of the lung clearance index to monitor progression of early lung disease in children with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016
Association between lobe specific bronchoalveolar lavage fluid metabolites and structural lung disease in young children with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015
Lung involvement in multiple myeloma - study case
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept